Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Cash from Investing Activities (2020 - 2021)

Historic Cash from Investing Activities for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to -$50.1 million.

  • Design Therapeutics' Cash from Investing Activities fell 260545.55% to -$50.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$53.6 million, marking a year-over-year decrease of 5984.03%. This contributed to the annual value of $44.0 million for FY2024, which is 1633.36% down from last year.
  • Per Design Therapeutics' latest filing, its Cash from Investing Activities stood at -$50.1 million for Q4 2021, which was down 260545.55% from -$5.0 million recorded in Q3 2021.
  • In the past 5 years, Design Therapeutics' Cash from Investing Activities ranged from a high of $23.0 million in Q1 2021 and a low of -$50.1 million during Q4 2021